Australia Stock Exchange release from NYRADA : Brain Injury Program Update and Pathway to Phase I
03/01/2022 21:22
Australia Stock Exchange release from NYRADA NYR.AX : Brain Injury Program Update and Pathway to Phase I
- AU$108.72m
- AU$100.34m
- AU$2.19m